National Asset Management, Inc. Insulet Corp Transaction History

National Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	BUY	$212.22 - $313.46 $213,917 - $315,967	1,008 New	1,008 $296,000
Q1 2021 May 13, 2021	SELL	$235.95 - $293.05 $6.44 Million - $7.99 Million	-27,281 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$215.97 - $265.89 $2.53 Million - $3.12 Million	-11,717 Reduced 30.05%	27,281 $6.98 Million
Q3 2020 Nov 09, 2020	BUY	$192.55 - $236.59 $4.53 Million - $5.57 Million	23,547 Added 152.4%	38,998 $8.55 Million
Q2 2020 Jul 31, 2020	BUY	$159.17 - $224.73 $2.46 Million - $3.47 Million	15,451 New	15,451 $3 Million

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.